WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATC 5th levels 2023

ATC codeATC level name
A01AB24octenidine
A01AB25oxytetracyline
A01AC04prednisolone
A02BX15teprenone
A03FA10acotiamide
A05BA10phospholipids
A06AX09elobixibat
A08AA51phentermine and topiramate
A10BX16tirzepatide
A10BX17carfloglitazar
A10BX18dorzagliatin
A16AB23cipaglucosidase alfa
A16AB24pegzilarginase
A16AB25olipudase alfa
A16AX21elivaldogene autotemcel
A16AX22tiomolibdic acid
B06AX04mitapivat
C01EB24mavacamten
C02KX54macitentan and tadalafil
C09BB13benazepril and amlodipine
C09DX08telmisartan, amlodipine and hydrochlorothiazide
C10BX19atorvastatin, amlodipine and candesartan
D01AC21neticonazole
D01AC22lanoconazole
D01AE25liranaftate
D11AH09ruxolitinib
G01AF21tinidazole
G02CX06fezolinetant
G04BD14imidafenacin
G04CA55doxazosin and finasteride
G04CB51finasteride and tadalafil
H01AC09lonapegsomatropin
H01CC53elagolix, estradiol and norethisterone
H02CA04levoketoconazole
H03AA51levothyroxine sodium and iodine compounds
H04AA02dasiglucagon
J01RA16cefixime and azithromycin
J02AX07ibrexafungerp
J02AX08rezafungin acetate
J04BA50dapsone and rifampicin
J04BA51dapsone, rifampicin and clofazimine
J05AB18molnupiravir
J05AE30nirmatrelvir and ritonavir
J06BD04ansuvimab
J06BD05sotrovimab
J06BD06regdanvimab
J06BD07casirivimab and imdevimab
J06BD08nirsevimab
J07AX01leptospira vaccines
J07BN01 1)covid-19, RNA-based vaccine
J07BN02 1)covid-19, viral vector, non-replicating
J07BN03 1)covid-19, inactivated virus
J07BN04 1)covid-19, protein subunit
J07XA01malaria vaccines
L01CD51paclitaxel and encequidar
L01EB09lazertinib
L01EB10mobocertinib
L01EB11aumolertinib
L01EG04sirolimus
L01EM05parsaclisib
L01EX24surufatinib
L01EX25umbralisib
L01FD06margetuximab
L01FX19sabatolimab
L01FX20tremelimumab
L01FX21naxitamab
L01FX22loncastuximab tesirine
L01FX23tisotumab vedotin
L01XL05ciltacabtagene autoleucel
L01XL06brexucabtagene autoleucel
L01XL07idecabtagene vicleucel
L01XX75tebentafusp
L01XX77adagrasib
L01XY03nivolumab and relatlimab
L03AA18efbemalenograstim alfa
L04AA57ublituximab
L04AA58efgartigimod alfa
L04AA59avacopan
L04AC23olokizumab
M03BX53pridinol, combinations
M05BX08menatetrenone
N04BA07foslevodopa and decarboxylase inhibitor
N05AH53olanzapine and samidorphan
N06AX29brexanolone
N06BA15dexmethylphenidate and serdexmethylphenidate
N07XX18vutrisiran
R02AD05ambroxol
R06AA61dimenhydrinate, combinations
S01AA29dibekacin
S01AA31cefmenoxime
S01AE09tosufloxacin
S01KX02trypan blue
S01LA09faricimab
S01XA28varenicline
S01XA29sepofarsen
S02AA17fosfomycin
S02AA18cefmenoxime
S03CA07methylprednisolone and antiinfectives
V04CX10pafolacianine
V08CA12gadopiclenol
V09AX07flortaucipir (18F)
V09IX15copper (64Cu) dotatate
V09IX16piflufolastat (18F)
V09IX17PSMA-1007 (18F)
V10XX05lutetium (177Lu) vipivotide tetraxetan
1) J07BX03 covid-19 vaccines deleted. Covid-19 vaccines subdivided into new 5th levels in a new 4th level J07BN.

Last updated: 2022-11-25